Last reviewed · How we verify
NCT04378829
Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19
trial testing Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19 in Covid-19 in 40 participants. Completed in 21 October 2020.
11 October 2020
Quick facts
| Lead sponsor | Konya Meram State Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 12 September 2020 |
| Primary completion | 11 October 2020 |
| Estimated completion | 21 October 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19
Conditions studied
- Covid-19 — all drugs for Covid-19 →
- Mean Platelet Volume — all drugs for Mean Platelet Volume →
- Platelet Destruction — all drugs for Platelet Destruction →
Sponsor
Konya Meram State Hospital
Who can join
Eligibility, any sex, with Covid-19 or Mean Platelet Volume. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will aim to investigate the relation of platelet count (PLT), mean platelet volume (MPV) and platelet distribution width (PDW) with other acute phase reactant c-reactive protein(CRP) in Coronavirus(COVID-19). As a methodology, patients will be selected in records in one month from the online hospital system. Two groups will be divided before as need for mechanical ventilation or not. The latter comparison will be about three groups as an ambulatory follow-up, hospital follow-up, and intensive care unit follow-up. Parameters will be analyzed according to the groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04378829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid-19
Currently open trials in the same condition.
- NCT05943743 — Hiccups and Obstacles Of E-Learning Among Medical Sudents · recruiting
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
- NCT04360538 — Long Term Outcomes of Patients With COVID-19 · active not recruiting
Other Konya Meram State Hospital trials
Trials by the same sponsor.
- NCT07458360 — FRONT Block for Quality of Recovery After Total Hip Arthroplasty · NA · not yet recruiting
- NCT05296187 — Efficacy of TEAS On Prevention of Propofol Injection Pain in Children · NA · completed
- NCT06940167 — Comparison of Kinesio Taping and Myofascial Release in Cervicogenic Headache · NA · completed
- NCT06349005 — Laryngoscopy and Coronary Artery Bypass Graft Surgery · NA · completed
- NCT06210126 — Pectointercostal Fascial Plane Block Chronic Pain Sternotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04378829 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Konya Meram State Hospital
- Last refreshed: 23 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04378829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing